We conduct analysis with immunohistochemistry to verify the knockdown efficiency of CCNB2 and in vivo experiments to prove that the knockdown of CCNB2 can indeed influence the progression of PCa once again. The gene discussed is CCNB2; the disease is posterior cortical atrophy.